Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

In a video interview with MHE editors, David Blair, founder, chairman, and CEO of LucyRx, expressed his belief that pharmacists are an underused resource in the U.S. healthcare system, especially at a ...

Pharmacies and PBMs face growing regulatory and reporting demands around drug pricing and reimbursement, while misalignment between state rules and payer practices complicates the expanded clinical ...

Dove’s new line of body care products was developed to address symptoms often associated with menopause, such as skin dryness and body odor.

An expert discusses how vitiligo treatment historically relied on off-label therapies such as topical corticosteroids, calcineurin inhibitors, and phototherapy, but now includes the first FDA-approved ...

The authors of an opinion piece in The Lancet Psychiatry make a case for paying more attention to the autistic features of ...

International audience surveys from last year’s menopause documentary, The (M) Factor, shed light on the ongoing need for ...

Pavblu, an Eylea HD biosimilar, shows stable vision outcomes and minimal side effects in real-world use, promising a reliable ...

In a video interview with MHE editors, Brian Anderson, MBA, a principal and consulting actuary at Milliman, shared his entry into the pharmacy benefits space was driven by a desire to improve ...

Veena Joy, the U.S. autoimmunity lead for medical and scientific affairs at Thermo Fisher Scientific, discusses the latest in ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Farxiga, along with insulin and monitoring for diabetic ketoacidosis, shows promise for kidney and glucose control in youth with Type 1 diabetes.